Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli

Biotechnology Journal

Volumn 6, Issue 5, 2011, Pages 604-608

  Tripathi, Nagesh K ^a,b   Shrivastava, Ambuj ^a   Biswal, Karttik C ^b   Rao, P V Lakshmana ^b  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Biochemical engineering; Dengue; ELISA; Media optimization; Process development

Indexed keywords

ANTIVIRAL THERAPY; CULTURE MEDIA; DENGUE; DENGUE VIRUS; DRY CELLS; E. COLI; ELISA; ENVELOPE DOMAINS; ENVELOPE PROTEINS; FED-BATCH CULTIVATION; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; MEDIA OPTIMIZATION; NEUTRALIZING ANTIBODIES; PROCESS DEVELOPMENT; PUBLIC HEALTH; PURIFIED PROTEIN; SDS-PAGE ANALYSIS; WESTERN BLOTTING;

AFFINITY CHROMATOGRAPHY; BIOCHEMICAL ENGINEERING; CELL CULTURE; ESCHERICHIA COLI; OPTIMIZATION; PROTEINS; PURIFICATION; VIRUSES;

BATCH CELL CULTURE;

ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE OPTIMIZATION; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FED BATCH CULTURE; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; RECOMBINANT DENGUE VIRUS TYPE 3 ENVELOPE DOMIAN 3 GENE; VIRUS GENE; VIRUS RECOMBINANT; WESTERN BLOTTING;

BIOENGINEERING; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS;

DENGUE VIRUS; DENGUE VIRUS TYPE 3; ESCHERICHIA COLI;

EID: 79955496104     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201000399     Document Type: Article

References (14)

1. Chin, J. F. L., Chu, J. J. H., Ng, M. L., The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect. 2007, 9, 1-6.
2. Guzman, M. G., Hermida, L., Bernardo, L., Ramirez, R., Guillen, G., Domain III of the envelope protein as a dengue vaccine target. Expert Rev. Vaccines 2010, 9, 137-147.
3. Pattnaik, P., Babu, J. P., Verma, S. K., Tak, V., Rao, P. V. L., Bacterially Expressed and Refolded Envelope protein (D III) of Dengue virus type 4 binds heparan sulphate. J. Chromatogr., B. 2007, 846, 184-194.
4. Jaiswal, S., Khanna, N., Swaminathan, S., High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli. Protein Expression Purif. 2004, 33, 80-91.
5. Tripathi, N. K., Babu, J.P., Shrivastva, A., Parida, M. et al., Production, and characterization of recombinant dengue virus type 4 envelope domain III protein. J. Biotechnol. 2008, 134, 278-286.
6. Chen, S., Yu, M., Jiang, T., Deng, Y. et al., Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein. DNA Cell Biol. 2007, 26, 361-367.
7. Khalilzadeh, R., Shojaosadati, S. A., Maghsoudi, N., Mohammadian-Mosaabadi, J. et al., Process development for production of recombinant human interferon-(expressed in E. coli. 2004, 31, 63-69.
8. Panda, A. K., Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli. Adv. Biochem. Eng. Biotechnol. 2003, 85, 43-93.
9. Tripathi, N. K., Shula, J., Biswal, K. C., Rao, P. V. L., Development of a simple fed-batch process for high yield production of Japanese encephalitis virus protein. Appl. Microbiol. Biotechnol. 2010, 86, 1795-1803.
10. Dash, P. K., Parida, M., Saxena, P., Abhyankar, A. et al., Re-emergence of dengue virus Type-3 (Subtype-III) in India: Implications for increased incidences of DHF and DSS. Virol. J. 2006, 3, 55.
11. Shrivastva, A., Tripathi, N. K., Parida, M., Dash, P. K. et al., Comparison of a dipstick enzyme-linked immunosorbent assay with commercial assays for detection of Japanese encephalitis virus-specific IgM antibodies. J. Postgrad. Med. 2008, 54, 181-185.
12. Tan, L. C. M., Ng, M. L., Dengue envelope domain III protein: Properties, production and potential applications in dengue diagnosis, in: Ganim, B., Reis, A. (Eds.), Dengue Virus: Detection, Diagnosis, and Control, Nova Science Publisher, NY, USA 2010, 53-70.
13. Chu, J. J. H., Rajamanonmani, R., Li, J., Bhuvanakantham, R. et al., Inhibition ofWest Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J. Gen. Virol. 2005, 86, 405-412.
14. Beasley, D. W. C., Holbrook, M. R., Amelia, P. A., Ros, T. et al., Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J. Clin. Microbiol. 2004, 42, 2759-2765.